(Q48607230)

13 February 2018

title

Brachytherapy of glioblastoma recurring in previously irradiated territory: predictive value of tumor volume (English)

1 reference

13 February 2018

1 reference

1 reference

Jean Marc Simon

1

1 reference

13 February 2018

Philippe Cornu

2

1 reference

13 February 2018

Gilbert Boisserie

3

1 reference

13 February 2018

Dominique Hasboun

4

1 reference

13 February 2018

Bernadette Tep

5

1 reference

13 February 2018

Claire Hardiman

6

1 reference

13 February 2018

Charles A Valery

7

1 reference

13 February 2018

Jean Yves Delattre

8

1 reference

13 February 2018

Didier Dormont

9

1 reference

13 February 2018

François Baillet

10

1 reference

13 February 2018

Jean Jacques Mazeron

11

1 reference

13 February 2018

language of work or name

English

0 references

publication date

1 May 2002

1 reference

13 February 2018

International Journal of Radiation Oncology Biology Physics

published in

1 reference

13 February 2018

volume

53

1 reference

13 February 2018

issue

1

1 reference

13 February 2018

page(s)

67-74

1 reference

13 February 2018

Chemotherapy for malignant gliomas

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902804-8

7 January 2021

Radiotherapy and chemotherapy for gliomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902804-8

7 January 2021

Recurrent malignant gliomas: survival following interstitial brachytherapy with high-activity iodine-125 sources

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902804-8

7 January 2021

Interstitial radiogold implantation for the treatment of recurrent high-grade gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902804-8

7 January 2021

Survival and quality of life after interstitial implantation of removable high-activity iodine-125 sources for the treatment of patients with recurrent malignant gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902804-8

7 January 2021

Clinical patterns of failure following stereotactic interstitial irradiation for malignant gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902804-8

7 January 2021

High activity iodine-125 interstitial implant for gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902804-8

7 January 2021

The relationship between the technical accuracy of stereotactic interstitial implantation for high grade gliomas and the pattern of tumor recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902804-8

7 January 2021

Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902804-8

7 January 2021

Stereotactic radiosurgery for recurrent gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902804-8

7 January 2021

Stereotactic radiosurgery for recurrent malignant gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902804-8

7 January 2021

Patterns of recurrence of malignant astrocytoma following stereotactic interstitial brachytherapy with iodine-125 implants.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902804-8

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902804-8

7 January 2021

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902804-8

7 January 2021

Measuring bias in uncontrolled brain tumor trials--to randomize or not to randomize?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902804-8

7 January 2021

Selection bias, survival, and brachytherapy for glioma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902804-8

7 January 2021

Assumptions in the radiotherapy of glioblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902804-8

7 January 2021

Treatment results of stereotactic interstitial brachytherapy for primary and metastatic brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902804-8

7 January 2021

The role of surgery in the management of supratentorial intermediate and high-grade astrocytomas in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902804-8

7 January 2021

Reoperation in the treatment of recurrent intracranial malignant gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902804-8

7 January 2021

Survival and functional status after resection of recurrent glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902804-8

7 January 2021

Reoperation for recurrent glioblastoma and anaplastic astrocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902804-8

7 January 2021

Patterns of second recurrence of malignant astrocytomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902804-8

7 January 2021

Surgery for glioma relapse. Factors that influence a favorable outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902804-8

7 January 2021

Multimodality management of recurrent adult malignant gliomas: results of a phase II multiagent chemotherapy study and analysis of cytoreductive surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902804-8

7 January 2021

Re-operations of supratentorial anaplastic astrocytomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902804-8

7 January 2021

Reoperation for malignant astrocytomas: personal experience and a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902804-8

7 January 2021

Inability of computed tomography appearance of recurrent malignant astrocytoma to predict survival following reoperation.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902804-8

7 January 2021

Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902804-8

7 January 2021

A comparison of techniques for stereotactic radiotherapy by linear accelerator based on 3-dimensional dose distributions

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902804-8

7 January 2021

Brachytherapy for recurrent malignant astrocytoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902804-8

7 January 2021

Cerebral astrocytomas: histopathologic correlation of MR and CT contrast enhancement with stereotactic biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902804-8

7 January 2021

Diagnostic yield in CT-guided stereotactic biopsy of gliomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902804-8

7 January 2021

Human cerebral gliomas: correlation of postmortem MR imaging and neuropathologic findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902804-8

7 January 2021

Long-term survival in patients with glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902804-8

7 January 2021

Long-term survival after the diagnosis of malignant glioma: a series of 22 patients surviving more than 4 years after diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902804-8

7 January 2021

Survival following interstitial brachytherapy for recurrent malignant glioma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902804-8

7 January 2021

10.1016/S0360-3016(01)02804-8

Identifiers

DOI

1 reference

13 February 2018

1 reference

13 February 2018